The G Protein-First Mechanism for Activation of the Class B Glucagon-like Peptide 1 Receptor Coupled to N-Terminal Domain-Mediated Conformational Progression.
G 蛋白優先機制在 N 端結構域介導的構象進展中激活 Class B Glucagon-like Peptide 1 受體。
J Am Chem Soc 2024-09-12
Differential Responses of the GLP-1 and GLP-2 Receptors to N-Terminal Modification of a Dual Agonist.
GLP-1和GLP-2受體對雙重激動劑N端修飾的差異反應。
J Am Chem Soc 2023-07-12
Selective polypeptide ligand binding to the extracellular surface of the transmembrane domains of the class B GPCRs GLP-1R and GCGR.
選擇性多肽配體結合到類B GPCR GLP-1R和GCGR的跨膜區域的細胞外表面。
iScience 2023-06-20
Structure and Molecular Mechanism of Signaling for the Glucagon-like Peptide-1 Receptor Bound to Gs Protein and Exendin-P5 Biased Agonist.
胰高血糖素樣肽-1受體與Gs蛋白及Exendin-P5偏向性激動劑結合的結構和信號傳遞的分子機制。
J Am Chem Soc 2024-01-11
Molecular features of the ligand-free GLP-1R, GCGR and GIPR in complex with G<sub>s</sub> proteins.
GLP-1R、GCGR和GIPR在與G<sub>s</sub>蛋白複合物中的無配體分子特徵。
Cell Discov 2024-02-15
The GLP-1R as a model for understanding and exploiting biased agonism in next-generation medicines.
GLP-1R作為理解和利用下一代藥物中偏向性激動作用的模型。
J Endocrinol 2024-04-17
Class B1 GPCRs: Insights into Multi-Receptor Pharmacology for the Treatment of Metabolic Disease.
B1類G蛋白偶聯受體:治療代謝性疾病的多受體藥理學洞見。
Am J Physiol Endocrinol Metab 2024-07-10